UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2023	$ 36	$ 593	$ (10,658)	$ 138,341	$ 128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options, shares	2
Common stock received and retired upon exercise of stock options	$ 0	96	0	0	96
Stock option compensation expense	0	79	0	0	79
Common stock purchased and retired	$ 0	(769)	0	(2,221)	(2,990)
Common stock purchased and retired, shares	(43)
Foreign currency translation adjustment	$ 0	0	(631)	0	(631)
Common stock dividends	0	0	0	(1,081)	(1,081)
Net income	0	0	0	3,956	3,956
Equity Balance, value at Mar. 31, 2024	$ 36	0	(11,289)	138,995	127,742
Equity Balance, shares at Mar. 31, 2024	3,588
Equity Balance, value at Dec. 31, 2023	$ 36	593	(10,658)	138,341	128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Stock option compensation expense					131
Foreign currency translation adjustment					(664)
Net income					7,409
Equity Balance, value at Jun. 30, 2024	$ 35	0	(11,322)	135,339	124,052
Equity Balance, shares at Jun. 30, 2024	3,499
Equity Balance, value at Mar. 31, 2024	$ 36	0	(11,289)	138,995	127,742
Equity Balance, shares at Mar. 31, 2024	3,588
Common stock issued upon exercise of employee stock options, shares	6
Common stock received and retired upon exercise of stock options	$ 0	294	0	0	294
Stock option compensation expense	0	52	0	0	52
Common stock purchased and retired	$ (1)	(346)	0	(6,056)	(6,403)
Common stock purchased and retired, shares	(95)
Foreign currency translation adjustment	$ 0	0	(33)	0	(33)
Common stock dividends	0	0	0	(1,052)	(1,052)
Net income	0	0	0	3,453	3,453
Equity Balance, value at Jun. 30, 2024	$ 35	0	(11,322)	135,339	124,052
Equity Balance, shares at Jun. 30, 2024	3,499
Equity Balance, value at Dec. 31, 2024	$ 33	0	(11,908)	129,302	117,427
Equity Balance, shares at Dec. 31, 2024	3,335
Stock option compensation expense	$ 0	82	0	0	82
Common stock purchased and retired	$ (1)	(82)	0	(3,138)	(3,221)
Common stock purchased and retired, shares	(54)
Foreign currency translation adjustment	$ 0	0	718	0	718
Common stock dividends	0	0	0	(1,001)	(1,001)
Net income	0	0	0	3,041	3,041
Equity Balance, value at Mar. 31, 2025	$ 33	0	(11,190)	128,204	117,047
Equity Balance, shares at Mar. 31, 2025	3,281
Equity Balance, value at Dec. 31, 2024	$ 33	0	(11,908)	129,302	117,427
Equity Balance, shares at Dec. 31, 2024	3,335
Stock option compensation expense					168
Foreign currency translation adjustment					2,546
Net income					6,089
Equity Balance, value at Jun. 30, 2025	$ 32	0	(9,362)	126,862	117,533
Equity Balance, shares at Jun. 30, 2025	3,216
Equity Balance, value at Mar. 31, 2025	$ 33	0	(11,190)	128,204	117,047
Equity Balance, shares at Mar. 31, 2025	3,281
Stock option compensation expense	$ 0	86	0	0	86
Common stock purchased and retired	$ (1)	(86)	0	(3,402)	(3,488)
Common stock purchased and retired, shares	(65)
Foreign currency translation adjustment	$ 0	0	1,828	0	1,828
Common stock dividends	0	0	0	(988)	(988)
Net income	0	0	0	3,048	3,048
Equity Balance, value at Jun. 30, 2025	$ 32	$ 0	$ (9,362)	$ 126,862	$ 117,533
Equity Balance, shares at Jun. 30, 2025	3,216